COMMUNIQUÉS West-GlobeNewswire

DBV Technologies publie ses résultats financiers du premier trimestre 2024 et fait le point sur ses activités
07/05/2024
Montrouge, France, le 7 mai DBV Technologies publie ses résultats financiers du premier trimestre 2024 et fait le point sur ses activités Recrutement de VITESSE en bonne voie pour l’inclusion du dernier patient au [...]
Lifeward to Report First Quarter Financial Results on May 15, 2024
07/05/2024
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, May 07, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward™), (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing [...]
Ultragenyx to Participate at Bank of America’s 2024 Healthcare Conference
07/05/2024
NOVATO, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and [...]
Aquestive Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
07/05/2024
Met all endpoints in Phase 3 pivotal study for Anaphylm™ (epinephrine) Sublingual Film in first quarter 2024 when compared to EpiPen ® and other injectors used for the treatment of anaphylaxis On track to complete [...]
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination with KEYTRUDA® (pembrolizumab)
07/05/2024
- CX-801 is a dually masked, conditionally activated IFNα2b cytokine designed using the CytomX Probody® Therapeutic Platform - - Phase 1 first-in-human study expected to start in first half of 2024 - - Clinical trial [...]
Certara Reports First Quarter 2024 Financial Results
07/05/2024
Reiterates Full Year 2024 Financial Guidance PRINCETON, N.J., May 07, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the first quarter [...]
Globus Medical Reports First Quarter 2024 Results
07/05/2024
AUDUBON, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended March 31, 2024. Worldwide net [...]
Spectral AI Announces 2024 First Quarter Financial Results
07/05/2024
Q1 Overview Research & Development Revenue of $6.3 Million Improved Capital Structure Reflected in Cash of $10.2 Million DeepView AI ® -Burn Devices Deployed in UK; Expect Commercial Revenue in 2H 2024 Additional [...]
Merus annonce l’acceptation par la FDA américaine et l’examen prioritaire de la demande de licence de produit biologique relative à Zeno dans le traitement du CPNPC et de l’ACP NRG1+
07/05/2024
S’il est approuvé, Zeno sera le premier traitement ciblé pour le cancer NRG1+ UTRECHT, Pays-Bas et CAMBRIDGE, Massachusetts, 07 mai 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : Merus (Merus, la Société, nous ou notre/ [...]
Adaptive Biotechnologies Reports First Quarter 2024 Financial Results
07/05/2024
SEATTLE, May 07, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive [...]
Avid Bioservices to Participate at Upcoming Investor Conferences
07/05/2024
TUSTIN, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high [...]
MaxCyte Reports First Quarter 2024 Financial Results and Updates 2024 Guidance
07/05/2024
MaxCyte Reports First Quarter 2024 Financial Results and Updates 2024 Guidance ROCKVILLE, MD, May 7, 2024 — MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling [...]
Oculis Publishes Invitation to the Annual General Meeting
07/05/2024
Zug, Switzerland, May 07, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq Global Market: OCS) (“Oculis”), has published the invitation to the 2024 Annual General Meeting, which will be held on 29 May 2024 at Ochsen- [...]
scPharmaceuticals to Announce First Quarter 2024 Financial Results on Tuesday, May 14, 2024
07/05/2024
Management to host conference call and webcast at 4:30 p.m. ET BURLINGTON, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and [...]
Terns Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference 2024
07/05/2024
FOSTER CITY, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product [...]
MaxCyte Reports First Quarter 2024 Financial Results and Updates 2024 Guidance
07/05/2024
ROCKVILLE, Md., May 07, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development, and [...]
Immuneering Reports First Quarter 2024 Financial Results and Provides Business Updates
07/05/2024
- Reported Positive Topline Results from Phase 1 Portion of its Phase 1/2a Clinical Trial of IMM-1-104 in RAS-Mutant Solid Tumors - - First Patient Dosed in Phase 2a Portion of Phase 1/2a Clinical Trial of IMM-1-104; [...]
ICU Medical Announces First Quarter 2024 Results
07/05/2024
SAN CLEMENTE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the [...]
Ocular Therapeutix™ Reports First Quarter 2024 Results
07/05/2024
Recent Leadership Appointments Put Ocular on Track to Become a Leader in Retinal Care Site Activation and Patient Enrollment for AXPAXLI™ SOL-1 Phase 3 wet AMD Trial Progressing with First Subjects Randomized in April [...]

Pages